| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 485 | 9800 | SH | Put | DFND | 1 | 9800 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 1216 | 24574 | SH | DFND | 24574 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 1157 | 23387 | SH | DFND | 1 | 23387 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006391 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | MACQUARIE GROUP LTD | 1418333 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 22 | 453 | SH | DFND | 3 | 0 | 453 | 0 | May 17th, 2022 01:38AM | May 17th, 2022 01:38AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006331 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Nuveen Asset Management, LLC | 1521019 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 635 | 12980 | SH | DFND | 3 | 12980 | 0 | 0 | May 17th, 2022 01:38AM | May 17th, 2022 01:38AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006331 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Nuveen Asset Management, LLC | 1521019 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 1422 | 29056 | SH | DFND | 4 | 29056 | 0 | 0 | May 17th, 2022 01:38AM | May 17th, 2022 01:38AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006197 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 932859 | EAGLE PHARMACEUTICALS INC | Common Stock | 269796108 | 4475 | 90414 | SH | SOLE | 50208 | 0 | 40206 | May 17th, 2022 01:37AM | May 17th, 2022 01:37AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006139 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | AMERIPRISE FINANCIAL INC | 820027 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 534 | 10789 | SH | DFND | 19 | 0 | 0 | 10789 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006139 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | AMERIPRISE FINANCIAL INC | 820027 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 1 | 29 | SH | DFND | 16 | 0 | 0 | 29 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:egrx | nasdaq:egrx Shareholders | 13F-HR | 0000950123-22-006139 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | AMERIPRISE FINANCIAL INC | 820027 | EAGLE PHARMACEUTICALS INC | COM | 269796108 | 2029 | 41000 | SH | DFND | 3 | 0 | 41000 | 0 | May 17th, 2022 01:36AM | May 17th, 2022 01:36AM | Eagle Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |